Breakthrough or risk? FDA approves Alzheimer's drug

Описание: U.S. regulators on Monday approved Biogen's aducanumab as the first treatment to attack a likely cause of Alzheimer's disease, despite controversy over whether the clinical evidence proves the drug works.

Visit us at https://www.inquirer.net
Facebook:   / inquirerdotnet  
Twitter:   / inquirerdotnet